Prestige Consumer Healthcare Inc. (PBH) Profit Margins
Over the twelve months to 2026-06-30, Prestige Consumer Healthcare Inc. (PBH) had gross margin 53.5%, operating margin 26.3%, net margin 15.6%, free cash flow margin 21.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PBHPrestige Consumer Healthcare Inc.Follow PBH — free
—
Price chart with a free account
- Market cap
- 2.3B
- P/E TTM
- 13.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2012 Mar 12 | FY2013 Mar 13 | FY2014 Mar 14 | FY2015 Mar 15 | FY2016 Mar 16 | FY2017 Mar 17 | FY2018 Mar 18 | FY2019 Mar 19 | FY2020 Mar 20 | FY2021 Mar 21 | FY2022 Mar 22 | FY2023 Mar 23 | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 51.6% | 55.4% | 56.2% | 56.8% | 57.9% | 56.7% | 55.4% | 56.9% | 57.3% | 58.0% | 57.1% | 55.4% | 55.5% | 55.8% | 54.7% | 53.5% | |
| Operating margin | 23.3% | 30.9% | 31.6% | 29.0% | 32.3% | 23.3% | 20.7% | 6.9% | 30.2% | 31.5% | 30.4% | -2.0% | 30.4% | 29.6% | 28.4% | 26.3% | |
| Net margin | 8.4% | 10.6% | 12.2% | 11.0% | 12.4% | 7.9% | 32.6% | -3.7% | 14.8% | 17.5% | 18.9% | -7.3% | 18.6% | 18.9% | 17.5% | 15.6% | |
| FCF margin | 15.2% | 20.5% | 18.2% | 21.0% | 21.4% | 16.5% | 19.0% | 18.3% | 21.0% | 22.6% | 23.0% | 19.7% | 21.3% | 21.4% | 22.6% | 21.3% |
USD billions · SEC XBRL
Prestige Consumer Healthcare Inc. — questions
- What is Prestige Consumer Healthcare Inc.'s gross margin?
- 53.5% over the twelve months to 2026-06-30.
- What is Prestige Consumer Healthcare Inc.'s operating margin?
- 26.3% over the twelve months to 2026-06-30.
- What is Prestige Consumer Healthcare Inc.'s net profit margin?
- 15.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Prestige Consumer Healthcare Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.